Patents by Inventor Quanyu ZHANG

Quanyu ZHANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200147172
    Abstract: The present invention relates to a use of cellular repressor of E1A-stimulated genes (CREG) protein, and in particular to a use of a CREG protein or an active fragment thereof in manufacture of a medicament for the prevention and/or treatment of a fatty liver disease and type 2 diabetes. The present invention also relates to a use of a recombinant vector or recombinant cell expressing a CREG protein or an active fragment thereof in manufacture of a medicament for the prevention and/or treatment of a fatty liver disease and type 2 diabetes. The invention also relates to a corresponding kit, such as a kit used for the predication and/or evaluation of therapeutic effect and prognosis of a fatty liver disease and type 2 diabetes.
    Type: Application
    Filed: December 21, 2017
    Publication date: May 14, 2020
    Inventors: Yaling HAN, Quanyu ZHANG, Chenghui YAN, Xiaoxiang TIAN
  • Publication number: 20190216894
    Abstract: Described is the use of an E1A activating gene repressor (CREG) protein, in particular to a use of a CREG protein or an active fragment thereof in manufacture of a medicament for prevention and/or treatment of overweight, obesity, insulin resistance, hyperlipidemia and related diseases. Also described is the use of a recombinant vector or recombinant cell expressing a CREG protein or an active fragment thereof in manufacture of a medicament for prevention and/or treatment of overweight, obesity, insulin resistance, hyperlipidemia and related diseases.
    Type: Application
    Filed: July 26, 2017
    Publication date: July 18, 2019
    Inventors: Yaling HAN, Xiaoxiang TIAN, Chenghui YAN, Quanyu ZHANG, Xiaolin ZHANG, Dan LIU